ANDA 208789, held by Ingenus Pharms LLC. Palonosetron Hydrochloride.
As of Nov 16, 2026, ANDA 208789 (Palonosetron Hydrochloride), held by Ingenus Pharms LLC, was first approved by FDA on May 22, 2020, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 22, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Palonosetron HydrochlorideEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) ยท injectable;intravenous | Palonosetron Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters